Annual Dividend Yield

Your own ranges are part of Powerpack. Powerpack

Annual Dividend Rate

Your own ranges are part of Powerpack. Powerpack

Payout Ratio

Your own ranges are part of Powerpack. Powerpack

Dividend Safety Score

Your own ranges are part of Powerpack. Powerpack

Dividend Champion (3y)
Dividend Champion (5y)
Dividend Champion (10y)
Dividend Aristocrat
Dividends Paid (Common)

Your own ranges are part of Powerpack. Powerpack

Issuance/Purchase of Shares

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow Yield

Your own ranges are part of Powerpack. Powerpack

Showing the 10 largest of 621 matches.
1 filter active
median
thirds
Free account

See all 621 matches

This screen shows only its 10 largest companies. A free account shows every match of every screen you run, and keeps one screen for you. No card.

Create free account
Powerpack

Export it, tune it, and hear when it changes

Download any screen to Excel, set your own range on any filter, and get an email the day a company enters or leaves a screen you saved.

Start 7-day free trial

Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time.

Also in Powerpack: every quarter, analyst estimates, API & MCP access. Compare plans

No.
1 VRTX Vertex Pharmaceuticals Incorporated (3.62%) 29.53% 20.49% — 8 9 — 0 19.37% (34.74%) 72.90% Yes
2 MRNA Moderna, Inc. (6.21%) — 1,192.59% — 2 4 — 0 101.85% — — No
3 REGN Regeneron Pharmaceuticals, Inc. 7.55% 11.11% (11.49%) — 10 10 0 0 12.31% (7.99%) 51.10% No
4 ARGX argenex SE (69.93%) — (46.04%) — 1 3 — 3 72.36% 35.36% — No
5 ONC BeOne Medicines Ltd. - Sponsored ADR (43.99%) — (6.72%) — 1 1 — 5 61.47% — — Yes
6 RPRX Royalty Pharma PLC 9.06% 27.98% 52.79% (39.35%) 8 5 5 0 21.87% (0.49%) 61.58% No
7 RVMD Revolution Medicines, Inc. — — 16.58% — 0 0 — — — — — No
8 GMAB Genmab A/S Sponsored ADR 3.11% 53.53% 44.63% — 9 9 — 4 5.78% (62.36%) 87.76% No
9 ROIV Roivant Sciences Ltd. (48.51%) — 3,337.67% — 1 0 — 0 7,896.59% 179.52% — No
10 INCY Incyte Corporation 10.85% 168.21% 7.74% — 8 8 — 2 10.05% 33.74% 64.64% Yes